Results 81 to 90 of about 6,034 (173)

Intermittent Oral Versus Intravenous Alfacalcidol in Dialysis Patients

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2000
Patients with end-stage renal failure (ESRF) on maintenance dialysis, commonly develop secondary hyperparathyroidism and renal osteodystrophy (ROD). Alfacalcidol, taken orally or administered intravenously, is known to reverse these complications.
Mitwalli Ahmed, Alam Awatif
doaj  

Increased PHOSPHO1 expression mediates cortical bone mineral density in renal osteodystrophy. [PDF]

open access: yesJ Endocrinol, 2022
Hsu SN   +10 more
europepmc   +1 more source

Cytokine accumulation in osteitis fibrosa of renal osteodystrophy

open access: yesBrazilian Journal of Medical and Biological Research, 2002
Bone marrow fibrosis occurs in association with a number of pathological states. Despite the extensive fibrosis that sometimes characterizes renal osteodystrophy, little is known about the factors that contribute to marrow accumulation of fibrous tissue.
Duarte M.E.L.   +4 more
doaj  

Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis Patients. [PDF]

open access: yesJBMR Plus, 2022
Sirimongkolchaiyakul O   +8 more
europepmc   +1 more source

Bone marrow adiposity inversely correlates with bone turnover in pediatric renal osteodystrophy. [PDF]

open access: yesBone Rep, 2021
Sirimongkolchaiyakul O   +5 more
europepmc   +1 more source

Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD. [PDF]

open access: yesKidney Int Rep, 2022
El-Husseini A   +10 more
europepmc   +1 more source

Renal osteodystrophy in Egyptian CKD patients: observations from clinically indicated bone biopsies. [PDF]

open access: yesBMC Nephrol
Elshabrawy N   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy